Identification of the role of VEGF receptors in bone remodeling by the vascular targeting agent VEGF121/rGel

被引：0
|
作者：
Mohamedali, Khalid A.
Poblenz, Ann T.
Kim, Sehoon
Yang, Jun
Navone, Nora M.
Thorpe, Philip
Darnay, Bryant
Rosenblum, Michael G.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3722
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Inhibition of prostate tumor growth and bone remodeling by the vascular targeting agent VEGF121/rGel
    Mohamedali, Khalid A.
    Poblenz, Ann T.
    Sikes, Charles R.
    Navone, Nora M.
    Thorpe, Philip E.
    Darnay, Bryant G.
    Rosenblum, Michael G.
    [J]. CANCER RESEARCH, 2006, 66 (22) : 10919 - 10928
  • [2] Photochemical internalization (PCI) of the vascular targeting immunotoxin VEGF121/rGel, a novel method for selective targeting of tumor vasculature
    Weyergang, Anette
    Berstad, Maria Eb
    Cheung, Lawrence H.
    Rosenblum, Michael
    Mohamedali, Khalid
    Waltenberger, Johannes
    Berg, Kristian
    [J]. CANCER RESEARCH, 2011, 71
  • [3] Pharmacodynamics, tissue distribution, toxicity studies and antitumor efficacy of the vascular targeting fusion toxin VEGF121/rGel
    Mohamedali, Khalid A.
    Niu, Gang
    Luster, Troy A.
    Thorpe, Philip E.
    Gao, Haokao
    Chen, Xiaoyuan
    Rosenblum, Michael G.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2012, 84 (11) : 1534 - 1540
  • [4] Photochemical internalization of VEGF121/rGel: a strategy for optimizing tumor-vasculature targeting.
    Weyergang, Anette
    Cheung, Lawrence H.
    Rosenblum, Michael
    Mohamedali, Khalid
    Waltenberger, Johannes
    Berg, Kristian
    [J]. CANCER RESEARCH, 2013, 73 (08)
  • [5] Inhibition of Prostate Cancer Osteoblastic Progression with VEGF121/rGel, a Single Agent Targeting Osteoblasts, Osteoclasts, and Tumor Neovasculature
    Mohamedali, Khalid A.
    Li, Zhi Gang
    Starbuck, Michael W.
    Wan, Xinhai
    Yang, Jun
    Kim, Sehoon
    Zhang, Wendy
    Rosenblum, Michael G.
    Navone, Nora M.
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (08) : 2328 - 2338
  • [6] The vascular-targeting fusion toxin VEGF121/rGel inhibits the growth of orthotopic human bladder carcinoma tumors
    Mohamedali, KA
    Kedar, D
    Sweeney, P
    Kamat, A
    Davis, DW
    Eve, BY
    Huang, S
    Thorpe, PE
    Dinney, CP
    Rosenblum, MG
    [J]. NEOPLASIA, 2005, 7 (10): : 912 - 920
  • [7] Photochemical internalization augments tumor vascular cytotoxicity and specificity of VEGF121/rGel fusion toxin
    Weyergang, Anette
    Cheung, Lawrence H.
    Rosenblum, Michael G.
    Mohamedali, Khalid A.
    Peng, Qian
    Waltenberger, Johannes
    Berg, Kristian
    [J]. JOURNAL OF CONTROLLED RELEASE, 2014, 180 : 1 - 9
  • [8] VEGF165 and VEGF121 differentially activate VEGF receptors.
    Yue, XP
    Tomanek, RJ
    [J]. FASEB JOURNAL, 2000, 14 (04): : A20 - A20
  • [9] A VEGF121-gelonin fusion protein (VEGF121/rGel) induces regression of subretinal and choroidal neovascularization (CNV)
    Akiyama, H
    Silva, RL
    Kachi, S
    Umeda, N
    Aslam, S
    Hackett, SF
    Mohamedali, K
    Rosenblum, MG
    Campochiaro, PA
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [10] The vascular-ablative agent VEGF121/rGel inhibits pulmonary Metastases of MDA-MB-231 breast tumors
    Ran, S
    Mohamedali, KA
    Luster, TA
    Thorpe, PE
    Rosenblum, MG
    [J]. NEOPLASIA, 2005, 7 (05): : 486 - 496
12345